GSK372475

DRUG4 trials

Sponsors

GlaxoSmithKline

Conditions

Depressive DisorderHealthy Subjects

Phase 1

GSK372475 Bioequivalence Study

CompletedNCT00488098

GlaxoSmithKlineDepressive Disorder, Healthy Subjects

Start: 2007-07-31Updated: 2012-06-04

GSK372475 PK Study in Healthy Volunteers

CompletedNCT00728208

GlaxoSmithKlineDepressive Disorder

Start: 2008-07-28End: 2008-12-29Updated: 2017-07-13

Phase 2

MDD POC Study GSK372475 Subjects Depressive Disease

CompletedNCT00420641

GlaxoSmithKlineDepressive Disorder

Start: 2006-12-19End: 2008-10-15Updated: 2018-02-05

A Study Of New Medicine (GSK 372475) For The Treatment Of Depression

CompletedNCT00448058

GlaxoSmithKlineDepressive Disorder

Start: 2007-04-30End: 2008-12-31Updated: 2014-10-10